Manufacturers and Filters – Is it all still a bit fuzzy? Bill Thomson, James Cullis, Joe OBrien Physics & Nuclear Medicine City Hospital. Birmingham City.
What makes clinical trials in orphan indications so special?
Orphan Drugs
EGAN tutorial: Loading experiment results October, 2009 Jesse Paquette UCSF Helen Diller Family Comprehensive Cancer Center [email protected].
Prospective study of EGFR intron 1 CA tandem repeats as predictive factor of benefit from cetuximab and irinotecan Antoniotti C 1, 2, Loupakis F 3, Cremolini.
Unit 04: BONDING
Exploring the use of mass spectrometry data for differential proteomics
